MYP_004183
Basic Information
CRT2 p128 (YYIMFGPDI)
Anticancer Tumor T-cell antigen
Immunology Epitope/vaccine antigen T-cell epitope
Immunology Immune modulation Immunomodulatory activity
Standard
9 amino acids
C55H75N9O14S
Standard
Sequence
YYIMFGPDI
Physicochemical Analysis
1118.30 Da
4.05
-1.24
-1.45
-0.1379
0.62
0.23
0.53
14.22
86.67
0.3333
2980.00
2980.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
365.09
0.87
12.0
14.0
31.0
79.0
4.0
8.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0263440 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Structure & Mods
topology not specified [Not included yet]
stereochemistry not specified [Other]
Bio-Activity Profile
Immunomodulatory Anticancer Tumor antigen T-cell epitope HLA-A24-restricted CTL epitope
HLA-A*24:02; HLA-A24-positive CRT2-expressing tumor cells
IFN-γ ELISPOT; CTL induction assay; 51Cr release cytotoxicity assay